Advertisement

Annals of Surgical Oncology

, Volume 26, Issue 5, pp 1238–1244 | Cite as

Impact of the SSO-ASTRO Margin Guideline on Rates of Re-excision After Lumpectomy for Breast Cancer: A Meta-analysis

  • Liska Havel
  • Himani Naik
  • Luis Ramirez
  • Monica Morrow
  • Jeffrey LandercasperEmail author
Breast Oncology

Abstract

Background

One in five patients undergoing initial lumpectomy for invasive breast cancer subsequently undergoes re-excision or mastectomy. A lack of clarity of when to re-excise based on lumpectomy margin width contributes to this high rate of reoperation. We sought to determine the impact of the Society of Surgical Oncology (SSO) and American Society of Radiation Oncologist (ASTRO) margin guideline on reoperation rates after lumpectomy. The guideline recommended omission of routine re-excision in specimens with “no ink on tumor”.

Methods

A systematic literature review was performed. For eligible studies, a random-effects model was used for a meta-analysis of lumpectomy re-excision prevalence before and after publication of the SSO-ASTRO margin guideline. Study heterogeneity was measured by the Cochran’s Q test.

Results

Five institutional, one population-based, and one national registry study met inclusion requirements. Sample size per study ranged from 237 to 26,102. There was significant interstudy heterogeneity (Q = 19.779; p = 0.003). Pooled re-excision prevalence was 22% (confidence interval [CI] 20–23) before and 14% (CI 12–15) after guideline publication. With the pre-guideline re-excision prevalence used as the reference value, the associated odds ratio for re-excision after the guideline was 0.65 (CI 0.54–0.78; p < 0.0001).

Conclusions

The findings of a 35% reduction in the odds of re-excision after the guideline publication and a reduction in re-excision prevalence from 22 to 14% supports the notion that the SSO-ASTRO margin guideline was impactful. These findings are congruent with the projected reductions in re-excision at the time of guideline publication.

Notes

Acknowledgment

The authors thank Paul Abrahamse for providing de-identified SEER data.18

Funding

All authors received financial support from the Gundersen Medical Foundation and the Gundersen Health System for this research. There was no funding from industry or other entities.

Conflict of interest

The authors declare that they have no conflict of interest.

Disclosure

Monica Morrow-Honoraria from Roche and Genomic Health

References

  1. 1.
    Cody III HS, Van Zee KJ. Reexcision—the other breast cancer epidemic. N Engl J Med. 2015;373:568–9.CrossRefGoogle Scholar
  2. 2.
    McCahill LE, Single RM, Bowles EJA, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307:467–75.CrossRefGoogle Scholar
  3. 3.
    Wilke LG, Czechura T, Wang C, et al. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the national cancer data base, 2004–2010. JAMA Surg. 2014;149:1296–305.CrossRefGoogle Scholar
  4. 4.
    van Leeuwen MT, Falster MO, Vajdic CM, et al. Reoperation after breast-conserving surgery for cancer in Australia: statewide cohort study of linked hospital data. BMJ Open. 2018;8:e020858.CrossRefGoogle Scholar
  5. 5.
    Jeevan R, Cromwell DA, Trivella M, et al. Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ. 2012;345:e4505.CrossRefGoogle Scholar
  6. 6.
    Rosenberger LH, Mamtani A, Fuzesi S, et al. Early adoption of the SSO-ASTRO consensus guidelines on margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: initial experience from Memorial Sloan Kettering Cancer Center. Ann Surg Oncol. 2016;23:3239–46.CrossRefGoogle Scholar
  7. 7.
    Schulman AM, Mirrielees JA, Leverson G, et al. Reexcision surgery for breast cancer: an analysis of the American Society of Breast Surgeons (ASBrS) Mastery SM database following the SSO-ASTRO “no ink on tumor” guidelines. Ann Surg Oncol. 2017;24:52–8.CrossRefGoogle Scholar
  8. 8.
    Landercasper J, Whitacre E, Degnim AC, Al-Hamadani M. Reasons for re-excision after lumpectomy for breast cancer: insight from the American Society of Breast Surgeons MasterySM database. Ann Surg Oncol. 2014;21:3185–91.CrossRefGoogle Scholar
  9. 9.
    Moran MS, Schnitt SJ, Giuliano AE, et al. Society of surgical oncology-American society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys. 2014;88:553–64.CrossRefGoogle Scholar
  10. 10.
    Houssami N, Macaskill P, Marinovich ML, Morrow M. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2014;21:717–30.CrossRefGoogle Scholar
  11. 11.
    Singer L, Brown E, Lanni Jr T. Margins in breast conserving surgery: the financial cost and potential savings associated with the new margin guidelines. Breast. 2016;28:1–4.CrossRefGoogle Scholar
  12. 12.
    Merrill AL, Coopey SB, Tang R, et al. Implications of new lumpectomy margin guidelines for breast-conserving surgery: changes in reexcision rates and predicted rates of residual tumor. Ann Surg Oncol. 2016;23:729–34.CrossRefGoogle Scholar
  13. 13.
    Greenup RA, Peppercorn J, Worni M, Hwang ES. Cost implications of the SSO-ASTRO consensus guideline on margins for breast-conserving surgery with whole breast irradiation in stage I and II invasive breast cancer. Ann Surg Oncol. 2014;21:1512–4.CrossRefGoogle Scholar
  14. 14.
    Baliski C, Pataky R. Influence of the SSO/ASTRO margin reexcision guidelines on costs associated with breast-conserving surgery. Ann Surg Oncol. 2017;24:632–7.CrossRefGoogle Scholar
  15. 15.
    Bhutiani N, Mercer MK, Bachman KC, et al. Evaluating the effect of margin consensus guideline publication on operative patterns and financial impact of breast cancer operation. J Am Coll Surg. 2018;227:6–11.CrossRefGoogle Scholar
  16. 16.
    Yu J, Elmore LC, Cyr AE, et al. Cost analysis of a surgical consensus guideline in breast-conserving surgery. J Am Coll Surg. 2017;225:294–301.CrossRefGoogle Scholar
  17. 17.
    Abe SE, Hill JS, Han Y, et al. Margin re‐excision and local recurrence in invasive breast cancer: a cost analysis using a decision tree model. J Surg Oncol. 2015;112:443–8.CrossRefGoogle Scholar
  18. 18.
    Morrow M, Abrahamse P, Hofer TP, et al. Trends in reoperation after initial lumpectomy for breast cancer: addressing overtreatment in surgical management. JAMA Oncol. 2017;3:1352–7.CrossRefGoogle Scholar
  19. 19.
    Chung A, Gangi A, Amersi F, et al. Impact of consensus guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on margins for breast-conserving surgery in stages 1 and 2 invasive breast cancer. Ann Surg Oncol. 2015;22:422–7.CrossRefGoogle Scholar
  20. 20.
    Patten CR, Walsh K, Sarantou T, et al. Changes in margin re‐excision rates: Experience incorporating the “no ink on tumor” guideline into practice. J Surg Oncol. 2017;116:1040–5.CrossRefGoogle Scholar
  21. 21.
    Gladden AAH, Sams S, Gleisner A, et al. Re-excision rates after breast conserving surgery following the 2014 SSO-ASTRO guidelines. Am J Surg. 2017;214:1104–9.CrossRefGoogle Scholar
  22. 22.
    Barendregt JJ, Doi SA, Lee YY, et al. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67:974–8.CrossRefGoogle Scholar
  23. 23.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRefGoogle Scholar
  24. 24.
    DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45:139–45.CrossRefGoogle Scholar
  25. 25.
    Adegboyega TO, Landercasper J, Linebarger JH, et al. Institutional review of compliance with NCCN guidelines for breast cancer: lessons learned from real-time multidimensional synoptic reporting. J Natl Compr Cancer Netw. 2015;13:177–83.CrossRefGoogle Scholar
  26. 26.
    Dull B, Linkugel A, Margenthaler JA, Cyr AE. Overuse of chest CT in patients with stage I and II breast cancer: an opportunity to increase guidelines compliance at an NCCN Member Institution. J Natl Compr Cancer Netw. 2017;15:783–9.CrossRefGoogle Scholar
  27. 27.
    Greenberg CC, Lipsitz SR, Hughes ME, et al. Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. Ann Surg. 2011;254:339–45.CrossRefGoogle Scholar
  28. 28.
    Landercasper J, Greenberg CC, Chen SL. Quality measures and outcomes for breast cancer surgery. In: Bland KI, Copeland III EM, Klimberg VS, Gradishar, editors. The breast comprehensive management of benign and malignant diseases. 5th edn. Philadelphia, PA: Elsevier; 2018. p. 499–513.Google Scholar
  29. 29.
    DeSnyder SM, Hunt KK, Smith BD, et al. Assessment of practice patterns following publication of the SSO-ASTRO consensus guideline on margins for breast-conserving therapy in stage I and II invasive breast cancer. Ann Surg Oncol. 2015;22:3250–6.CrossRefGoogle Scholar
  30. 30.
    Landercasper J, Attai D, Atisha D, et al. Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: the American Society of Breast Surgeons Consensus Conference. Ann Surg Oncol. 2015;22:3174–83.CrossRefGoogle Scholar
  31. 31.
    Chagpar AB, Killelea BK, Tsangaris TN, et al. A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med. 2015;373:503–10.CrossRefGoogle Scholar
  32. 32.
    Jones V, Linebarger J, Perez S, et al. Excising additional margins at initial breast-conserving surgery (BCS) reduces the need for re-excision in a predominantly African American population: a report of a randomized prospective study in a public hospital. Ann Surg Oncol. 2016;23(2):456–64.CrossRefGoogle Scholar
  33. 33.
    Eck DL, Koonce SL, Goldberg RF, et al. Breast surgery outcomes as quality measures according to the NSQIP database. Ann Surg Oncol. 2012;19:3212–7.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  • Liska Havel
    • 1
  • Himani Naik
    • 1
  • Luis Ramirez
    • 1
  • Monica Morrow
    • 2
  • Jeffrey Landercasper
    • 1
    Email author
  1. 1.Gundersen Medical FoundationLa CrosseUSA
  2. 2.Breast Service, Department of SurgeryMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations